Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, 1 Youyi Rd, Yuanjiagang, Yuzhong District, Chongqing, 400016, People's Republic of China.
Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Cancer Imaging. 2024 Jun 17;24(1):76. doi: 10.1186/s40644-024-00717-4.
A standard surgical procedure for patients with small early-stage lung adenocarcinomas remains unknown. Hence, we aim in this study to assess the clinical utility of the consolidation-to-tumor ratio (CTR) when treating patients with small (2 cm) early stage lung cancers.
A retrospective cohort of 298 sublobar resection and 266 lobar resection recipients for early stage lung adenocarcinoma ≤ 2 cm was assembled from the First Affiliated Hospital of Chongqing Medical University between 2016 and 2019. To compare survival rates among the different groups, Kaplan-Meier curves were calculated, and the log-rank test was used. A multivariate Cox proportional hazard model was constructed utilizing variables that were significant in univariate analysis of survival.
In the study, 564 patients were included, with 298 patients (52.8%) undergoing sublobar resection and 266 patients (47.2%) undergoing lobar resection. Regarding survival results, there was no significant difference in the 5-year overall survival (OS, P = 0.674) and 5-year recurrence-free survival (RFS, P = 0.253) between the two groups. Cox regression analyses showed that CTR ≥ 0.75(P < 0.001), age > 56 years (P = 0.007), and sublobar resection(P = 0.001) could predict worse survival. After examining survival results based on CTR categorization, we segmented the individuals into three categories: CTR<0.7, 0.7 ≤ CTR<1, and CTR = 1.The lobar resection groups had more favorable clinical outcomes than the sublobar resection groups in both the 0.7 ≤ CTR < 1(RFS: P < 0.001, OS: P = 0.001) and CTR = 1(RFS: P = 0.001, OS: P = 0.125). However, for patients with 0 ≤ CTR < 0.7, no difference in either RFS or OS was found between the lobar resection and sublobar resection groups, all of which had no positive events. Patients with a CTR between 0.7 and 1 who underwent lobar resection had similar 5-year RFS and OS rates compared to those with a CTR between 0 and 0.7 who underwent sublobar resection (100% vs. 100%). Nevertheless, a CTR of 1 following lobar resection resulted in notably reduced RFS and OS when compared to a CTR between 0.7 and 1 following lobar resection (P = 0.005 and P = 0.016, respectively).
Lobar resection is associated with better long-term survival outcomes than sublobar resection for small lung adenocarcinomas ≤ 2 cm and CTR ≥ 0.7.
对于小的早期肺腺癌患者,仍然没有标准的手术程序。因此,我们旨在本研究中评估在治疗 2cm 以下的小(2cm)早期肺癌患者时,肿瘤与肺实质比值(CTR)的临床实用性。
回顾性收集了 2016 年至 2019 年重庆医科大学第一附属医院 298 例亚肺叶切除术和 266 例肺叶切除术治疗早期≤2cm 肺腺癌患者的队列。为了比较不同组的生存率,计算了 Kaplan-Meier 曲线,并使用对数秩检验。利用单变量生存分析中具有统计学意义的变量构建了多变量 Cox 比例风险模型。
本研究共纳入 564 例患者,其中 298 例(52.8%)接受亚肺叶切除术,266 例(47.2%)接受肺叶切除术。关于生存结果,两组 5 年总生存率(OS,P=0.674)和 5 年无复发生存率(RFS,P=0.253)无显著差异。Cox 回归分析显示,CTR≥0.75(P<0.001)、年龄>56 岁(P=0.007)和亚肺叶切除术(P=0.001)可预测较差的生存。根据 CTR 分类检查生存结果后,我们将个体分为三组:CTR<0.7、0.7≤CTR<1 和 CTR=1。肺叶切除术组在 0.7≤CTR<1(RFS:P<0.001,OS:P=0.001)和 CTR=1(RFS:P=0.001,OS:P=0.125)的两组中的临床结局均优于亚肺叶切除术组。然而,对于 0≤CTR<0.7 的患者,肺叶切除术和亚肺叶切除术组在 RFS 或 OS 方面均无差异,且均无阳性事件。CTR 在 0.7 到 1 之间且行肺叶切除术的患者与 CTR 在 0 到 0.7 之间且行亚肺叶切除术的患者的 5 年 RFS 和 OS 率相似(100% vs. 100%)。然而,与 CTR 在 0.7 到 1 之间且行肺叶切除术相比,行肺叶切除术且 CTR 为 1 的患者的 RFS 和 OS 明显降低(P=0.005 和 P=0.016)。
对于 2cm 以下且 CTR≥0.7 的小肺腺癌,肺叶切除术与亚肺叶切除术相比,具有更好的长期生存结局。